SCHEMBL31346262

SCHEMBL31346262

CNc1nc2nc3ccccc3n2cc1-c1ccc(Cl)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
LMNA P02545 3/20 0.45
ADORA2A P29274 2/20 0.44
TOP2A P11388 1/20 0.42
POLB P06746 3/20 0.42
ALDH1A1 P00352 4/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
BMX P51813 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
HPGD P15428 2/20 0.38
GALR3 O60755 1/20 0.37
NR2F2 P24468 1/20 0.37
TP53 P04637 2/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31346258 0.85 ADORA2A (0.48) KDM4EKMT2AMEN1RAB9ANPC1
SCHEMBL2816214 0.74 ADORA2A (0.63) KDM4EKMT2AMEN1RAB9ANPC1
SCHEMBL29892566 0.71 ADORA2A (0.49) KDM4EKMT2AMEN1RAB9ANPC1
SCHEMBL31346231 0.67 BMX (0.58) KDM4EKMT2AMEN1RAB9ANPC1
SCHEMBL31346253 0.66 SMN1; SMN2 (0.52) KDM4EKMT2AMEN1RAB9ANPC1
SCHEMBL2816389 0.66 HTR2C (0.47) KDM4EKMT2AMEN1RAB9ANPC1
SCHEMBL11823273 0.65 ALDH1A1 (0.50) KDM4EKMT2AMEN1LMNAADORA2A
SCHEMBL31346257 0.65 TNKS (0.53) KDM4EKMT2ARAB9ANPC1POLB
SCHEMBL2818071 0.64 GAA (0.48) KDM4ELMNAADORA2ATOP2AALDH1A1
SCHEMBL11738659 0.64 KMT2A (0.51) KDM4EKMT2AMEN1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114423763-B Regioselective synthesis of imidazo [1,2-a ] pyrimidines 豪夫迈·罗氏有限公司 2025-01-21 CN disclosed